BloggingStocks has a new home! Daily Finance.

Click here to visit the new home of BloggingStocks!

Hot on DailyFinance:

See More Stories

AOL
MAIL

Option Update: Amgen volatility elevated into FDA Oncologic Drugs Advisory Committee

Posted Mar 12th 2008 9:44AM by Paul Foster
Filed under: Amgen Inc (AMGN), Options

Amgen (NASDAQ: AMGN) closed at $44.62 Tuesday.

On 3/13/08, the FDA Oncologic Drugs Advisory Committee (ODAC) is scheduled to review the use of Erythropoiesis stimulation agents, including Aranesp and JNJ's Procrit, to treat chemotherapy induced anemia.

AMGN March option implied volatility is at 51; April is at 41; above its 26-week average of 33 according to Track Data, suggesting larger price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Tags: amgen, amgn, aranesp, epogen, jnj, johnson and johnson, JohnsonAndJohnson, option implied volatility, OptionImpliedVolatility, procrit

Indexes	Change	Price
DJIA	+80.45	12,881.68
NASDAQ	+26.73	2,930.61
S&P 500	+9.77	1,352.41

Last updated: February 13, 2012: 02:48 PM

Hot Stocks

General Electric

19.055+0.18(+0.95)

Alcoa

10.33+0.04(+0.39)

Apple Inc

501.14+7.72(+1.56)

Google Inc 'A'

613.17+7.26(+1.20)

Bank of America

8.295+0.225(+2.79)

Wal-Mart Stores

61.89-0.01(-0.02)

Exxon Mobil Corp

84.53+0.73(+0.87)

Ford

12.60+0.16(+1.29)

Citigroup

33.33+0.405(+1.23)

IBM

192.98+0.56(+0.29)

Yahoo

16.140.00(0.00)

Starbucks

49.20+0.38(+0.78)

Microsoft

30.705+0.21(+0.69)

Home Depot

46.095+0.765(+1.69)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1329162510588 ms.